U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with L

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138112 Q3 2022 LACTOSE MONOHYDRATE ORAL TABLET, COATED PARTICLES 150.00 mg Deletion
138289 Q2 2022 LACTOSE MONOHYDRATE ORAL GRANULE, FOR SOLUTION 1691.80 mg MDE Replacement
138290 Q3 2022 LACTOSE MONOHYDRATE ORAL GRANULE, FOR SOLUTION 846mg MDE Replacement
138291 Q2 2022 LACTOSE MONOHYDRATE ORAL TABLET, FOR SUSPENSION 543.60 mg MDE Replacement
138292 Q3 2022 LACTOSE MONOHYDRATE ORAL TABLET, FOR SUSPENSION 2794mg MDE Replacement
138293 Q2 2022 LECITHIN ORAL SUSPENSION 110.00 mg/ 1.00 ml MDE Replacement
138294 Q3 2022 LECITHIN ORAL SUSPENSION 150mg MDE Replacement
138295 Q2 2022 LIME OIL, COLD PRESSED ORAL LOZENGE 0.42 mg MDE Replacement
138296 Q3 2022 LIME OIL, COLD PRESSED ORAL LOZENGE 10mg MDE Replacement
138297 Q2 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, DELAYED RELEASE 30.99 mg MDE Replacement
138298 Q3 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, DELAYED RELEASE 103mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top